Cargando…
Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study
Non-Hodgkin lymphoma (NHL) is characterized by a great variability in patient outcomes, resulting in the critical need for identifying new molecular prognostic biomarkers. This study aimed to identify novel circulating prognostic biomarkers based on an miRNA/lncRNA-associated ceRNA network for NHL....
Autores principales: | Fernandes, Mara, Marques, Herlander, Teixeira, Ana Luísa, Medeiros, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219780/ https://www.ncbi.nlm.nih.gov/pubmed/35740344 http://dx.doi.org/10.3390/biomedicines10061322 |
Ejemplares similares
-
ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort
por: Fernandes, Mara, et al.
Publicado: (2021) -
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine
por: Fernandes, Mara, et al.
Publicado: (2021) -
Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives
por: Fernandes, Mara, et al.
Publicado: (2021) -
The ceRNA network of lncRNA and miRNA in lung cancer
por: Seo, Danbi, et al.
Publicado: (2020) -
Bioinformatics analysis of lncRNA‑associated ceRNA network in melanoma
por: Ding, Yi, et al.
Publicado: (2021)